Suppr超能文献

将液体反应性的动态评估纳入目标导向治疗:一项系统评价和荟萃分析。

Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis.

作者信息

Bednarczyk Joseph M, Fridfinnson Jason A, Kumar Anand, Blanchard Laurie, Rabbani Rasheda, Bell Dean, Funk Duane, Turgeon Alexis F, Abou-Setta Ahmed M, Zarychanski Ryan

机构信息

1Section of Critical Care, Department of Medicine, Max Rady College of Medicine, University of Manitoba, Health Sciences Centre, Winnipeg, MB, Canada.2Department of Anesthesia and Perioperative Medicine, Western University, University Hospital, London, ON, Canada.3Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.4George & Fay Yee Center for Healthcare Innovation, University of Manitoba/Winnipeg Regional Health Authority, Winnipeg, MB, Canada.5Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine and Population Health and Optimal Health Practices Unit (Trauma-Emergency-Critical Care Medicine), CHU de Québec-Université Laval Research Center, Université Laval, Quebec City, QC, Canada.

出版信息

Crit Care Med. 2017 Sep;45(9):1538-1545. doi: 10.1097/CCM.0000000000002554.

Abstract

OBJECTIVE

Dynamic tests of fluid responsiveness have been developed and investigated in clinical trials of goal-directed therapy. The impact of this approach on clinically relevant outcomes is unknown. We performed a systematic review and meta-analysis to evaluate whether fluid therapy guided by dynamic assessment of fluid responsiveness compared with standard care improves clinically relevant outcomes in adults admitted to the ICU.

DATA SOURCES

Randomized controlled trials from MEDLINE, EMBASE, CENTRAL, clinicaltrials.gov, and the International Clinical Trials Registry Platform from inception to December 2016, conference proceedings, and reference lists of relevant articles.

STUDY SELECTION

Two reviewers independently identified randomized controlled trials comparing dynamic assessment of fluid responsiveness with standard care for acute volume resuscitation in adults admitted to the ICU.

DATA EXTRACTION

Two reviewers independently abstracted trial-level data including population characteristics, interventions, clinical outcomes, and source of funding. Our primary outcome was mortality at longest duration of follow-up. Our secondary outcomes were ICU and hospital length of stay, duration of mechanical ventilation, and frequency of renal complications. The internal validity of trials was assessed in duplicate using the Cochrane Collaboration's Risk of Bias tool.

DATA SYNTHESIS

We included 13 trials enrolling 1,652 patients. Methods used to assess fluid responsiveness included stroke volume variation (nine trials), pulse pressure variation (one trial), and stroke volume change with passive leg raise/fluid challenge (three trials). In 12 trials reporting mortality, the risk ratio for death associated with dynamic assessment of fluid responsiveness was 0.59 (95% CI, 0.42-0.83; I = 0%; n = 1,586). The absolute risk reduction in mortality associated with dynamic assessment of fluid responsiveness was -2.9% (95% CI, -5.6% to -0.2%). Dynamic assessment of fluid responsiveness was associated with reduced duration of ICU length of stay (weighted mean difference, -1.16 d [95% CI, -1.97 to -0.36]; I = 74%; n = 394, six trials) and mechanical ventilation (weighted mean difference, -2.98 hr [95% CI, -5.08 to -0.89]; I = 34%; n = 334, five trials). Three trials were adjudicated at unclear risk of bias; the remaining trials were at high risk of bias.

CONCLUSIONS

In adult patients admitted to intensive care who required acute volume resuscitation, goal-directed therapy guided by assessment of fluid responsiveness appears to be associated with reduced mortality, ICU length of stay, and duration of mechanical ventilation. High-quality clinical trials in both medical and surgical ICU populations are warranted to inform routine care.

摘要

目的

在目标导向治疗的临床试验中已开展并研究了液体反应性的动态测试。这种方法对临床相关结局的影响尚不清楚。我们进行了一项系统评价和荟萃分析,以评估与标准治疗相比,基于液体反应性动态评估指导的液体治疗是否能改善入住重症监护病房(ICU)的成人患者的临床相关结局。

数据来源

检索MEDLINE、EMBASE、CENTRAL、clinicaltrials.gov以及国际临床试验注册平台自创建至2016年12月的随机对照试验、会议论文集以及相关文章的参考文献列表。

研究选择

两名研究者独立识别比较入住ICU的成人患者急性容量复苏时液体反应性动态评估与标准治疗的随机对照试验。

数据提取

两名研究者独立提取试验水平的数据,包括人群特征、干预措施、临床结局和资金来源。我们的主要结局是最长随访期的死亡率。次要结局包括ICU住院时间、医院住院时间(住院时长)、机械通气时间以及肾脏并发症的发生率。使用Cochrane协作网的偏倚风险工具对试验的内部效度进行了重复评估。

数据综合

我们纳入了13项试验共1652例患者。用于评估液体反应性的方法包括每搏量变异(9项试验)、脉压变异(1项试验)以及被动抬腿/液体负荷试验时的每搏量变化(3项试验)。在12项报告死亡率的试验中,与液体反应性动态评估相关的死亡风险比为0.59(95%CI,0.42 - 0.83;I² = 0%;n = 1586)。与液体反应性动态评估相关的死亡率绝对风险降低为 -2.9%(95%CI,-5.6%至 -0.2%)。液体反应性动态评估与ICU住院时间缩短相关(加权均数差值,-1.16天[95%CI,-1.97至 -0.36];I² = 74%;n = 394,6项试验)以及机械通气时间缩短相关(加权均数差值,-2.98小时[95%CI,-5.08至 -0.89];I² = 34%;n = 334,5项试验)。3项试验的偏倚风险判定为不清楚;其余试验存在高偏倚风险。

结论

在需要急性容量复苏的入住重症监护的成年患者中,基于液体反应性评估指导的目标导向治疗似乎与死亡率降低、ICU住院时间缩短以及机械通气时间缩短相关。有必要在医疗和外科ICU人群中开展高质量临床试验,为常规治疗提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cc0/5555977/362a2f7da9d0/ccm-45-1538-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验